-+ 0.00%
-+ 0.00%
-+ 0.00%

IONIS PHARMACEUTICALS - CARDIO-TTRANSFORM PHASE 3 TRIAL FOR EPLONTERSEN MISSES PRIMARY ENDPOINT UP TO WEEK 140

Reuters·07/09/2026 06:00:01

Please log in to view news